Evidence map›Paper›PMID 39638611›Full record

ArticleBMJ global health2024

Evaluation of a strategic academic-government partnership to advance COVID-19 clinical practice guidelines access and uptake in South Africa.

Bey-Marrie Schmidt, Tamara Kredo, Trudy Desirie D Leong, Taryn Young, Nasreen Jessani

Abstract read
In one paragraph

Article in BMJ global health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Bey-Marrie SchmidtHealth Systems Research Unit, South African Medical Research Council, Tygerberg, Western Cape, South Africa bey-marrie.schmidt@mrc.ac.za.ORCID http://orcid.org/0000-0003-1363-171X
Tamara KredoHealth Systems Research Unit, South African Medical Research Council, Tygerberg, Western Cape, South Africa.ORCID http://orcid.org/0000-0001-7115-9535
Trudy Desirie D LeongHealth Systems Research Unit, South African Medical Research Council, Cape Town, South Africa.ORCID http://orcid.org/0000-0003-2687-7751
Taryn YoungCentre for Evidence-based Health Care, Division Epidemiology and Biostatistics, Department of Global Health, Stellenbosch University, Cape Town, South Africa.ORCID http://orcid.org/0000-0003-2406-081X
Nasreen JessaniDepartment of Global Health, Stellenbosch University, Stellenbosch, South Africa.ORCID http://orcid.org/0000-0002-1160-3099

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAcademic-government partnerships are important to advance timely, responsive and relevant evidence for decision-making (policy, guideline, law and regulation) deliberations. Deliberate and strategic integrated knowledge translation (KT) approaches within such partnerships have been shown to facilitate evidence-informed decision-making (EIDM). We used Cochrane's KT Framework to map and analyse COVID-19 response activities instituted by a strategic academic-government partnership to support EIDM during the COVID-19 pandemic in South Africa.

methodsWe used Cochrane's KT Framework to map and analyse COVID-19 response activities instituted by a strategic academic-government partnership to support EIDM during the COVID-19 pandemic in South Africa. The COVID-19 response activities included coproducing rapid therapeutics reviews, engaging stakeholders with review evidence, packaging and disseminating review products, facilitating access to rapid reviews for evidence users and adapting partnership processes for rapid review production.

resultsThis paper highlights the importance of (a) authentic partnerships between evidence producers and users (motivated by context-specific goals, trust and relationships); (b) intentional and systematic stakeholder engagement to promote the rapid exchange of information; (c) using tailored, responsive and relevant KT to promote the uptake of evidence and (d) monitoring and evaluating the implementation of KT to identify lessons learnt and adaptation of KT approaches.

conclusionIn responding to future emergencies, a comprehensive KT strategy, including the expertise of KT practitioners and science communicators to make evidence and guideline recommendations accessible, should be embedded. Additionally, streamlining bureaucratic processes for approving and communicating information; identifying and addressing decision-maker capacity needs; engaging a range of stakeholders and integrating KT in usual decision-making processes, is recommended. Adequate investment by governments is needed for sustaining KT approaches that can enhance EIDM for improving public health outcomes.

Indexed as

COVID-19Practice Guidelines as TopicSARS-CoV-2GovernmentHumansSouth AfricaTranslational Research, BiomedicalDecision MakingGlobal HealthHealth systemsPublic HealthQualitative study

Identifiers

PMID39638611
PMCPMC11624732

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.